Phase I/II Study of TSU-68 for Advanced Hepatocellular Carcinoma

Clinical trial NCT00784290 · COMPLETED

Trial details

NCT number: NCT00784290
Sponsor: Taiho Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2003-09-01
Primary completion: 2010-10-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.